(Q43828376)

27 November 2017

title

The evolving role of tor inhibitors for individualizing posttransplant immunosuppression (English)

1 reference

27 November 2017

1 reference

Lorber MI

1

1 reference

27 November 2017

Basadonna GP

2

1 reference

27 November 2017

Friedman AL

3

1 reference

27 November 2017

Lorber KM

4

1 reference

27 November 2017

Bia MJ

5

1 reference

27 November 2017

Formica R

6

1 reference

27 November 2017

Smith JD

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Transplantation Proceedings

27 November 2017

published in

1 reference

27 November 2017

volume

33

1 reference

27 November 2017

issue

7-8

1 reference

27 November 2017

page(s)

3075-3077

1 reference

Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902311-9

7 January 2021

10.1016/S0041-1345(01)02311-9

Identifiers

DOI

1 reference

27 November 2017

1 reference